IN2013MU03311A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03311A
IN2013MU03311A IN3311MU2013A IN2013MU03311A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A IN 3311MU2013 A IN3311MU2013 A IN 3311MU2013A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A
Authority
IN
India
Prior art keywords
burns
leaving
treatment
active ingredients
scar mark
Prior art date
Application number
Other languages
English (en)
Inventor
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Original Assignee
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Surendra Kumar Gupta, Ankita Gupta, Sakshi Gupta filed Critical Dr Surendra Kumar Gupta
Priority to IN3311MU2013 priority Critical patent/IN2013MU03311A/en
Publication of IN2013MU03311A publication Critical patent/IN2013MU03311A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
IN3311MU2013 2013-10-22 2013-10-22 IN2013MU03311A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (ko) 2013-10-22 2013-10-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (ko) 2013-10-22 2013-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03311A true IN2013MU03311A (ko) 2015-07-17

Family

ID=54397351

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3311MU2013 IN2013MU03311A (ko) 2013-10-22 2013-10-22

Country Status (1)

Country Link
IN (1) IN2013MU03311A (ko)

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
PH12017500941A1 (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
PH12019502646A1 (en) Pyrazole magl inhibitors
MX380250B (es) Compuestos farmacéuticos inhibidores de cinasa chk-1.
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
MD3204025T2 (ro) Compoziții care conțin tulpini bacteriene
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
EA201790273A1 (ru) Флагеллиновые композиции и их применение
CR20150462A (es) Inhibidores de erk y sus usos
PH12015500525A1 (en) Formulations of enzalutamide
PH12015502161A1 (en) Therapeutic compounds and compositions
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
MX2017004808A (es) Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2016014559A (es) Compuestos para el tratamiento de cancer.
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
GEP20186920B (en) Halogenated quinazolinthf-amines as pde1 inhibitors
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата